Paul Y. Song - 27 Nov 2023 Form 4 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Chief Executive Officer, Director
Signature
/s/ Paul Y. Song, M.D.
Issuer symbol
NKGN
Transactions as of
27 Nov 2023
Net transactions value
+$701
Form type
4
Filing time
28 Nov 2023, 16:10:01 UTC
Previous filing
22 Nov 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKGN Common Stock Purchase $300 +103 +0.06% $2.91 170,561 27 Nov 2023 Direct
transaction NKGN Common Stock Purchase $400 +140 +0.08% $2.85 170,701 27 Nov 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.